Temozolomide-induced desquamative skin rash in a patient with metastatic melanoma

Pharmacology, Toxicology and Pharmaceutical Science

• Rash 100%
• Metastatic Melanoma 100%
• Temozolomide 100%
• Adverse Event 20%
• Adverse Drug Reaction 20%
• Metastasis 10%
• Bone Marrow Suppression 10%
• Antibiotic Agent 10%
• Headache 10%
• Alkylating Agent 10%
• Constipation 10%
• Nausea and Vomiting 10%
• Pruritus 10%
• Dermatological Agent 10%
• Topical Corticosteroid 10%

Keyphrases

• Naranjo Adverse Drug Reaction Probability Scale 14%
• Moisturizing Cream 14%